EG-011

N/A

Report date: 2023/10/26 17:10:22

Base Information

Drug NameEG-011
Drug Alias NameEG-011Ad-VEGF-D
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adenoviral vector
Mechanisms of ActionVascular endothelial growth factor D stimulantsGene transference
TargetsVascular endothelial growth factor D
Therapy Area/IndicationsAngina Pectoris
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesArk Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesArk Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsAngina Pectoris
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A